{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:03:52Z","timestamp":1747184632995,"version":"3.40.5"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There are established guidelines for treatment and monitoring of chronic myeloid leukemia (CML) but little is known about routine care. Data on ICD\u201010 codes as well as prescribed medications were available for 10.5\u00a0million patients in the statutory health insurance system in Bavaria for the years 2010 to 2016. Also, data on the molecular and cytogenetic monitoring were integrated. A total of 1714 adult patients with CML were observed. Only 50.8% received more than 67.5 daily doses per quarter year (target: 91.5) while 18.2% did not receive any tyrosine kinase inhibitor (TKI). The median number of daily doses was at least 80 doses per quarter year for all age groups in men, but decreased to 62 doses in elderly women. With this exception, no differences between men and women were observed. The percentage of patients without any TKI increased with age. The median number of molecular examinations was 3.54 independent of age and sex. Even in a highly developed country, still a considerable number of patients with CML seem to not receive adequate treatment, whereas molecular monitoring can be considered satisfactory.<\/jats:p>","DOI":"10.1111\/ejh.13293","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T01:53:36Z","timestamp":1563242016000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population\u2010based study"],"prefix":"10.1111","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6662-7127","authenticated-orcid":false,"given":"Michael","family":"Lauseker","sequence":"first","affiliation":[{"name":"Institute for Medical Information Sciences, Biometry, and Epidemiology Ludwig\u2010Maximilians\u2010Universit\u00e4t Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Gerlach","sequence":"additional","affiliation":[{"name":"Kassen\u00e4rztliche Vereinigung Bayerns Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenke","family":"Worseg","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Tauscher","sequence":"additional","affiliation":[{"name":"Kassen\u00e4rztliche Vereinigung Bayerns Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Hasford","sequence":"additional","affiliation":[{"name":"Institute for Medical Information Sciences, Biometry, and Epidemiology Ludwig\u2010Maximilians\u2010Universit\u00e4t Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena S.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Institute for Medical Information Sciences, Biometry, and Epidemiology Ludwig\u2010Maximilians\u2010Universit\u00e4t Munich Germany"},{"name":"Department of Infectious Diseases &amp; Tropical Medicine Ludwig\u2010Maximilians\u2010Universit\u00e4t Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2041-0"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324228"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23330"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.01.017"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0088-6"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-319038"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196543"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22019"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.10.1006"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2372-z"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.812034"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.904281"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1913.1913"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.862251"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2155-y"},{"key":"e_1_2_8_19_1","unstructured":"EMA.Summary of product characteristics \u2010 Glivec. 2016 [cited 2016 August 1st 2016]. Available from:http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000406\/WC500022207.pdf."},{"key":"e_1_2_8_20_1","unstructured":"EMA.Summary of product characteristics \u2010 Iclusig. 2016 [cited 2016 August 1st 2016]. Available from:http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Iclusig_20\/European_Commission_final_decision\/WC500183635.pdf."},{"key":"e_1_2_8_21_1","unstructured":"EMA.Summary of product characteristics \u2010 Sprycel. 2016 [cited 2016 August 1st 2016]. Available from:http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/000709\/WC500056993.pdf."},{"key":"e_1_2_8_22_1","unstructured":"EMA.Summary of product characteristics \u2010 Tasigna. 2016 [cited 2016 August 1st 2016]. Available from:http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000798\/WC500034394.pdf."},{"key":"e_1_2_8_23_1","unstructured":"EMA.Summary of product characteristics \u2010 Bosulif. 2016 [cited 2016 August 1st 2016]; Available from:http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002373\/WC500141721.pdf."},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12977"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.246"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-495598"},{"volume-title":"Allgemeine Sterbetafel \u2010 Methodische Erl\u00e4uterungen und Ergebnisse 2010\/12","year":"2015","author":"R\u00f6\u00dfger F","key":"e_1_2_8_27_1"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.261"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr060"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00048-4"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241050-00002"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12362"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2385-7"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0598"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-539742"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903396469"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.13293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ejh.13293","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.13293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:05:18Z","timestamp":1693548318000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.13293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1111\/ejh.13293"],"URL":"https:\/\/doi.org\/10.1111\/ejh.13293","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"type":"print","value":"0902-4441"},{"type":"electronic","value":"1600-0609"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"2019-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}